• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; PRECISE PRO RX (NIM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; PRECISE PRO RX (NIM) Back to Search Results
Model Number PC0840RXC
Device Problem Failure To Adhere Or Bond (1031)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/28/2016
Event Type  malfunction  
Manufacturer Narrative
The product is not available for analysis.The lot number has been updated, and the device history report is pending.Additional information is pending and will be submitted within 30 days.
 
Event Description
As reported, the precise pro rx stent bunched at the distal end.Deployment resistance was average.Additional information has been requested.
 
Manufacturer Narrative
Complaint conclusion-the precise pro rx stent bunched at the distal end.Deployment resistance was average.There was no other product issue noted either at the account, after the procedure, or prior to shipping for inspection.There was no patient injury.The procedure was completed with the product in question.The product was stored, handled, inspected and prepped according to the instructions for use.There was nothing unusual noted about the stent delivery system prior to use.This was a non-stenotic vessel; it was stenting for non-stenosis vulnerable plaque.The size sheath introducer used was 6 fr.The diameter of the unconstrained stent size was 1-2 mm larger than the vessel diameter.The target lesion vessel length was approximately 30 mm.Stenosis of the target lesion was less than 30%.The lesion was not calcified and not tortuous.The stent delivery system passed through acute bends.The delivery of the sds (stent delivery system) to the lesion was ipsilateral.There was no difficulty encountered while advancing/tracking the sds towards the lesion.The product was not returned for analysis.A device history record (dhr) review of lot 17555265 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿stent-ses incomplete expansion¿ could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.Procedural factors such as the correct positioning of the stent delivery system before and during stent deployment may have contributed to the reported event.According to the instructions for use ¿slack removal a.Advance the stent delivery system past the lesion site.B.Pull back the stent delivery system until the radiopaque inner shaft markers (leading and trailing ends) move in position so that they are proximal and distal to the target lesion.C.Ensure that the stent delivery system outside the patient remains flat and straight.Caution: slack in the catheter shaft either outside or inside the patient may result in deploying the stent beyond the lesion site.5.Stent deployment note: when ready to proceed with stent deployment, heparin may be administered per standard hospital practice or as prescribed by a physician.Heparin may be continued following stent deployment if so indicated by a physician or hospital protocol.A.Verify that the delivery system¿s radiopaque inner shaft markers (leading and trailing ends) are proximal and distal to the target lesion.B.Unlock the tuohy borst valve connecting the inner shaft and outer sheath of the delivery system.C.Ensure that the access sheath or guiding catheter does not move during deployment.D.Initiate stent deployment by retracting the outer sheath while holding the inner shaft in a fixed position.Deployment is complete when the outer sheath marker passes the proximal inner shaft stent marker.Note: the mechanism for stent deployment is outer sheath retraction.Deployment is completed by maintaining inner shaft position while retracting the outer sheath and allowing the stent to expand (often referred to as the ¿pin-and-pull¿ method).¿ neither the dhr nor the information available suggests a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX US CAROTID SYST
Type of Device
PRECISE PRO RX (NIM)
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th ave
miami lakes FL 33014
Manufacturer (Section G)
CORDIS DE MEXICO
circuito int nte 1820
juarez 32580
MX   32580
Manufacturer Contact
cecil navajas
14201 nw 60th ave
miami lakes, FL 33014
MDR Report Key6050528
MDR Text Key58195877
Report Number9616099-2016-00670
Device Sequence Number1
Product Code NIM
UDI-Device Identifier20705032036495
UDI-Public20705032036495
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/24/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2018
Device Model NumberPC0840RXC
Device Catalogue NumberPC0840RXC
Device Lot Number17555265
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date09/30/2016
Date Manufacturer Received09/30/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/26/2016
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-